Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 4Colonic Neoplasms 4Rectal Neoplasms 3Colorectal Neoplasms 3Neoplasms 2Liver Neoplasms 2Cholangiocarcinoma 2Vipoma 1Stomach Neoplasms 1Stage IV Fallopian Tube Cancer AJCC v6 and v7 1Somatostatinoma 1Pseudomyxoma Peritonei 1Pheochromocytoma 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms, Unknown Primary 1Nasopharyngeal Carcinoma 1Insulinoma 1Hyperthermia 1Glucagonoma 1Gastrointestinal Stromal Tumors 1Gastrinoma 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Islet Cell 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1

Interventions

Melphalan 3Leucovorin 1Hyperthermia, Induced 1Floxuridine 1Diathermy 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Hyperthermia × Floxuridine × Clear all
NCT00001576 2008-03-04

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
28 enrolled
Gastrointestinal

Hyperthermia, Liver Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡